Anzeige
Mehr »
Login
Dienstag, 21.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
1.885 Leser
Artikel bewerten:
(2)

SaaS Management Platform Torii Announces $3.5M Seed Round at Toronto's Collision Conference

Finanznachrichten News

As SaaS Management Takes Off, Torii Differentiates by Offering Solutions for Real-time "Autonomous IT"

TORONTO, ON / ACCESSWIRE / May 21, 2019 / Speaking from the stage at Collision, North America's fastest-growing tech conference, Torii CEO Uri Haramati announced today that his company has closed a $3.5 million seed round led by Uncork Capital, with additional investments from Global Founders Capital and Entrée Capital.

"In the near future, people will not need to manage software - it will be software that manages software," said Haramati. "This inevitability is the anchor of our vision for Torii - to create one software that manages all software, seamlessly, automatically and in real-time. And for that, you need a searchable and easily managed system of record, topped by a powerful and versatile engine for automated workflows. SaaS management needs the ability to automatically add and remove accounts, to optimize license utilization and to intelligently route alert notifications to the right stakeholders."

Benedikt Körling of Global Founders Capital believes that SaaS management will become an increasingly important category, "especially SaaS automation, which Torii tackles well," he said. "Torii's product is more sophisticated than many other offerings on the market today. It shows the founding team's deep product understanding, providing IT teams with an unprecedented user experience."

Andy McLoughlin of Uncork Capital said, "We chose to invest in Torii because we loved the team, the product, the early traction, and the market. The three founders are experienced tech innovators - they bring valuable experience working in high growth businesses, coupled with developing consumer products. This unique combination makes them an exceptionally compelling founding team. I think you only have to look at the quality of the product they are building and early customer traction to understand that."

Above, left to right: Torii co-founders Tal Bereznitskey, CTO; Uri Haramati, CEO; Uri Nativ, VP Engineering

One of Palo Alto's hottest VC funds, Uncork is known for its many portfolio success stories, including Eventbrite, SendGrid, Fitbit, About.me, Bitly and Mint. Global Founders Capital, on the other hand, is among Berlin's most globally active VC organizations, having invested in companies like Facebook, LinkedIn, Trivago, Slack and Canva.

Torii's solution tackles a pain point many CIOs and IT managers face, with employees often adopting scores of SaaS applications on a self-service basis, making SaaS a primary culprit of the dreaded "shadow IT" phenomenon. In the age of GDPR compliance and elusive cyber threats, regaining control of all software in use in the enterprise is a mission-critical imperative.

Torii's tools allow IT managers to discover, audit, vet and control the SaaS apps that employees use and to make sure license utilization is optimized. To top that, workflow management can be automated, freeing the IT team up from many of their tedious, regularly mistake-prone processes.

Above: Torii's automated workflow editor

Haramati sees the custom workflow automation capabilities of Torii as a key differentiator, one which will only strengthen its market positioning as post-funding development continues. "We started out focusing on SaaS visibility, then we added a layer of insights, and now a layer of workflow automation to provide our users with the value they need in a way that fits their challenges," he explained.

The seed round will allow Torii to pursue the next phase in its development roadmap, which will see them adding more sophisticated and customizable automation components into their product. It will also allow them to build a US-based sales and customer success team to handle the demand for the platform.

Torii is already being used by top brands and companies such as Monday.com, SimilarWeb, Typeform, Payoneer, ClassPass, Delivery Hero and Thrive Global.

About Torii

Torii offers a SaaS management solution that helps enterprises effectively manage their SaaS application use and subscriptions. The company was founded in 2017 and is currently based in Raanana, Israel and New York.

Torii's team is led by CEO Uri Haramati, a veteran product leader who previously co-founded Life on Air (Meerkat and Houseparty). With him in the executive team are Engineering VP Uri Nativ and CTO Tal Bereznitskey. Naveen Zutshi, the CIO of Palo Alto Networks, is also joining Torii's team as an advisor.

For more information: www.toriihq.com

Press contact:

Dan Edelstein
pr@inboundjunction.com
+972-545-464-238

SOURCE: Torii



View source version on accesswire.com:
https://www.accesswire.com/546047/SaaS-Management-Platform-Torii-Announces-35M-Seed-Round-at-Torontos-Collision-Conference

© 2019 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.